Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome.

  title={Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome.},
  author={George Q. Daley and Richard A. Van Etten and David Baltimore},
  volume={247 4944},
In tumor cells from virtually all patients with chronic myelogenous leukemia, the Philadelphia chromosome, a fusion of chromosomes 9 and 22, directs the synthesis of the P210bcr/abl protein. The protein-tyrosine kinase activity and hybrid structure of P210bcr/abl are similar to the oncogene product of the Abelson murine leukemia virus, P160gag/v-abl, which induces acute lymphomas. To determine whether P210bcr/abl can induce chronic myelogenous leukemia, murine bone marrow was infected with a… CONTINUE READING
Highly Influential
This paper has highly influenced 45 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS


Publications citing this paper.
Showing 1-10 of 765 extracted citations

Animal models of leukemia: any closer to the real thing?

Cancer and Metastasis Reviews • 2012
View 16 Excerpts
Highly Influenced

Re-evaluating the role of BCR/ABL in chronic myelogenous leukemia

Molecular & cellular oncology • 2014
View 14 Excerpts
Highly Influenced

Ponatinib in refractory Philadelphia chromosome-positive leukemias.

The New England journal of medicine • 2012
View 6 Excerpts
Highly Influenced

Myeloid Leukemia

Methods In Molecular Medicine™ • 2006
View 10 Excerpts
Highly Influenced

Basic science going clinical: molecularly targeted therapy of chronic myelogenous leukemia

Journal of Cancer Research and Clinical Oncology • 2004
View 8 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…